Showing results (631-640 of 701) with videos related to

Sort By:
Pageof 71
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 12, 2024
The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trialParminder K Judge, Katherine R Tuttle, Natalie Staplin, et al.
The New England Journal of Medicine|March 4, 2026
Finerenone in Type 1 Diabetes and Chronic Kidney DiseaseHiddo J L Heerspink, Andreas L Birkenfeld, David Z I Cherney, et al.
Diabetes, Obesity & Metabolism|February 16, 2021
Metformin and carotid intima-media thickness in never-smokers with type 1 diabetes: The REMOVAL trialJoseph G Timmons, Nicola Greenlaw, James G Boyle, et al.
European Heart Journal|August 30, 2024
Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trialKenneth W Mahaffey, Katherine R Tuttle, Mustafa Arici, et al.
Elife|December 11, 2019
Linking glycemic dysregulation in diabetes to symptoms, comorbidities, and genetics through EHR data miningIsa Kristina Kirk, Christian Simon, Karina Banasik, et al.
American Journal of Nephrology|October 14, 2020
A Targeted Multiomics Approach to Identify Biomarkers Associated with Rapid eGFR Decline in Type 1 DiabetesChristine P Limonte, Erkka Valo, Daniel Montemayor, et al.
Journal of the American College of Cardiology|June 3, 2026
Kidney and Survival Benefits of Semaglutide in Diabetes With Chronic Kidney Disease: FLOW Trial Cardiovascular Subgroup AnalysesKatherine R Tuttle, George L Bakris, Florian M M Baeres, et al.
Frontiers in Endocrinology|March 17, 2023
Four missense genetic variants in CUBN are associated with higher levels of eGFR in non-diabetes but not in diabetes mellitus or its subtypes: A genetic association study in EuropeansNicoline Uglebjerg, Fariba Ahmadizar, Dina M Aly, et al.
Kidney International Reports|November 14, 2017
Prediction of Chronic Kidney Disease Stage 3 by CKD273, a Urinary Proteomic BiomarkerClaudia Pontillo, Zhen-Yu Zhang, Joost P Schanstra, et al.
Kidney International|October 22, 2022
Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidencePeter Rossing, M Luiza Caramori, Juliana C N Chan, et al.
Pageof 71